Endoplasmic Reticulum Stress in Diseases
Ed. by Blumental-Perry, Anna / Wang, X. Robert
1 Issue per year
The journal Endoplasmic Reticulum Stress in Diseases (ERSD) focuses on the biology of endoplasmic reticulum (ER) stress and its impact on the development and progression of various human disorders ranging from carcinogenesis and inflammation to metabolic and neurodegenerative diseases. The journal welcomes both in vitro and in vivo studies that contribute to the understanding of the pathophysiology and the development of novel therapeutics to relevant diseases.
Aims and Scope
The journal focuses on the latest insights to the roles of the ER stress in the development and progression of relevant human pathological conditions. Involvement of ER stress in human diseases is a fast growing field with tremendous potential to identify novel drug targets. However, most of the work is scattered in various journals dealing with specific diseases. The primary mission of ERSD is to become a central publication venue for all members of the research community working on different aspects of ER function and malfunction in pathogenesis of human diseases, in order to ensure more efficient and productive exchange of research ideas, technologies and therapeutic options.
ERSD is an open access, peer-reviewed journal. The journal is led by an Editorial Board of the internationally recognized scientists, and publishes up-to-date research, commentaries and leading reviews.
Authors benefit from
- fast, fair and constructive peer review
- articles placed on-line within 10 days of acceptance and proofing
- language editing service for accepted articles
- no limit on article length or the number of color figures
- authors allowed to retain copyright to their work
- waiver of publications charges up till 2017
- Emerging Science
- Type of Publication:
- Research in the field of the biology of endoplasmic reticulum.
Submission of Manuscripts
Instructions for Authors
Manuscripts should be submitted to the journal at http://www.editorialmanager.com/ersd.
Authors are suggested to follow Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (ICMJE).
Manuscript submitted to this journal should:
- contain original work - not published elsewhere in any medium (in the whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
- focus on the aims and scope of the journal;
- be clearly and correctly written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
- written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
- be delivered in electronic format.
The journal accepts the following publication formats:
- Research Articles
- Communications and Rapid Communications
- Reviews and Mini-Reviews
- Letters to the Editor and Amendments
It is important that authors include a cover letter with their manuscript. Please explain why you consider your manuscript as suitable for publication in the journal, why will your paper inspire the other members of your field, and how will it drive research forward.
The letter should contain all important details such as:
- your full name (submitted by)
- full title of article and short title
- full list of authors with affiliations
- e-mail of the corresponding author
- contact address, telephone/fax numbers of the corresponding author
- number of attached files, if there is more than one
- status: new, reviewed or accepted (with reference ID if reviewed or accepted)
Cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be made available. Reviewers will be asked to comment on the overlap between the related submissions.
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Conflict of interest declaration
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Journal Editor.
Open Access License
Authors have to sign an Open Access License that is available on the journal webpage. We encourage the authors to send the signed license along with the manuscript. Please note, that no article will be published unless the Open Access License is signed.
We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.
- Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below)
- Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see below). Please note that a straight Excel file is not an acceptable format
- Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please note that Powerpoint files are not accepted
Post acceptance, text files of the revised manuscript and tables are required for use in the production.
Authors should clearly indicate location of tables and figures in the text if these elements are given separately or at the end of the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the end of the text.
For further instructions, please carefully follow the guidelines described in Instructions for Authors.
Abstracting & Indexing
Endoplasmic Reticulum Stress in Diseases is covered by the following services:
- Baidu Scholar
- Chemical Abstracts Service (CAS) - CAplus
- Chemical Abstracts Service (CAS) - SciFinder
- CNKI Scholar (China National Knowledge Infrastructure)
- EBSCO (relevant databases)
- EBSCO Discovery Service
- Elsevier - Embase
- Elsevier - Reaxys
- Elsevier - Text Mining
- Google Scholar
- KESLI-NDSL (Korean National Discovery for Science Leaders)
- Microsoft Academic
- Naviga (Softweco)
- Polish Scientific Journals Database
- Primo Central (ExLibris)
- Summon (Serials Solutions/ProQuest)
- Ulrich's Periodicals Directory/ulrichsweb
- WanFang Data
- WorldCat (OCLC)
Anna Blumental-Perry, Case Western Reserve University, USA
X. Robert Wang, Samford University, USA
Cristina Scapin, San Raffaele Scientific Institute, Italy
Editorial Advisory Board
Simone Cenci, San Raffaele Scientific Institute, Italy
Eric Chevet, University of Bordeaux, France
Julio A. Aguirre-Ghiso, The Mount Sinai School of Medicine, USA
Maurizio Grimaldi, Southern Research Institute, USA
Peter Hersey, The University of Sydney, Australia
Guido Kroemer, University of Paris Descartes, France
Guang Liang, Wenzhou Medical College, China
Bo Lu, Thomas Jefferson University, USA
Yasuyuki Nomura, Yokohama College of Pharmacy, Japan
Matthias Ocker, Bayer Healthcare Pharmaceuticals and Charite University Medicine Berlin, Germany
Erik Lee Snapp, Albert Einstein College of Medicine, USA
Boaz Tirosh, The Hebrew University of Jerusalem, Israel
Danyelle M. Townsend, University of South Carolina, USA
Maurizio Zanetti, University of California San Diego, USA
Editorial Review Board
Hiderou Yoshida, University of Hyogo, Japan
Matteo Landriscina, University of Foggia, Italy
Frank Thévenod, University of Witten-Herdecke, Germany
Rahul Srinivasan, Texas A&M University, USA
Marek Michalak, University of Alberta, Canada
Yasuyuki Nomura, Kurume University School of Medicine, Japan
Robert Clarke, Georgetown University, USA
Prakash Kulkarni, University of Maryland, USA
Matthias Ocker, Oncology Biomarker Strategy, Bayer AG, Germany
Jonathan Lin, UC San Diego, USA
Jozsef Mandl, Semmelweis University, Hungary
Frédéric Gachon, Nestle Institute of Health Sciences, Switzerland
Michael Pagliassotti, Colorado State University, USA
Oleksandr Minchenko, Palladin Institute of Biochemistry, Ukraine
Martin Duennwald, Schulich School of Medicine and Dentistry, University of Western Ontario, Canada
Danyelle M. Townsend, University of South Carolina, USA
Shinsuke Matsuzaki, Wakayama Medical University, Japan
Edward Avezov, University of Cambridge, England
DE GRUYTER Poland
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15